Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Metsu

Showing results (1-10 of 17) with videos related to

Pageof 2
Sort By:
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|May 10, 2025
Evaluating dosing accuracy and galenic dispersion quality in Hospital-Based pediatric spironolactone oral suspensionRoxanne Desquines, Romain Gallissot, Caroline Viard, et al.
Clinical Nutrition (Edinburgh, Scotland)|August 5, 2025
Is blood vitamin B6 a marker of interest for individualized psoriasis disease care management in cardiovascular disease prevention?David Metsu, Cristina Bulai Livideanu, Elise Deveza, et al.
Journal of Evaluation in Clinical Practice|May 16, 2018
The Electronic Pharmaceutical Record: A new method for medication reconciliationCamille Jurado, Violaine Calmels, Emilie Lobinet, et al.
Annals of Clinical Biochemistry|August 1, 2023
Analytical assays and bootstrap resampling method to validate performance of the Roche Elecsys STAT highly sensitive troponin T assay and its application for the 'rule-out' part of ESC guidelines for NTSTEMIDavid Metsu, Daphné Mille, Carole Pailly, et al.
Diagnostic Microbiology and Infectious Disease|June 5, 2024
Non-O1/non-O139 Vibrio cholerae bacteremia and hepatitis in diabetic patient, France, winter 2019Sebastien Laurens, Nathalie Wilhelm, Frédéric Février, et al.
Clinical Therapeutics|October 8, 2013
Ceftazidime dosage recommendations in burn patients: from a population pharmacokinetic approach to clinical practice via Monte Carlo simulationsJean-Marie Conil, Bernard Georges, François Ravat, et al.
Fundamental & Clinical Pharmacology|September 25, 2016
Is the unbound concentration of atazanavir of interest in therapeutic drug monitoring?David Metsu, Patrick Seraissol, Pierre Delobel, et al.
Infection|February 28, 2019
Efficacy of teicoplanin monotherapy following initial standard therapy in Enterococcus faecalis infective endocarditis: a retrospective cohort studyThomas De Nadaï, Mathilde François, Agnès Sommet, et al.
Viruses|July 21, 2019
Plasma Hepatitis E Virus Kinetics in Solid Organ Transplant Patients Receiving RibavirinSebastien Lhomme, Swati DebRoy, Nassim Kamar, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|December 27, 2017
Determination of dolutegravir's unbound fraction in human plasma using validated equilibrium dialysis and LC-MS/MS methodsDavid Metsu, Thomas Lanot, François Fraissinet, et al.
Pageof 2

Showing results (1-10 of 17) with videos related to

Sort By:
Pageof 2
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|May 10, 2025
Evaluating dosing accuracy and galenic dispersion quality in Hospital-Based pediatric spironolactone oral suspensionRoxanne Desquines, Romain Gallissot, Caroline Viard, et al.
Clinical Nutrition (Edinburgh, Scotland)|August 5, 2025
Is blood vitamin B6 a marker of interest for individualized psoriasis disease care management in cardiovascular disease prevention?David Metsu, Cristina Bulai Livideanu, Elise Deveza, et al.
Journal of Evaluation in Clinical Practice|May 16, 2018
The Electronic Pharmaceutical Record: A new method for medication reconciliationCamille Jurado, Violaine Calmels, Emilie Lobinet, et al.
Annals of Clinical Biochemistry|August 1, 2023
Analytical assays and bootstrap resampling method to validate performance of the Roche Elecsys STAT highly sensitive troponin T assay and its application for the 'rule-out' part of ESC guidelines for NTSTEMIDavid Metsu, Daphné Mille, Carole Pailly, et al.
Diagnostic Microbiology and Infectious Disease|June 5, 2024
Non-O1/non-O139 Vibrio cholerae bacteremia and hepatitis in diabetic patient, France, winter 2019Sebastien Laurens, Nathalie Wilhelm, Frédéric Février, et al.
Clinical Therapeutics|October 8, 2013
Ceftazidime dosage recommendations in burn patients: from a population pharmacokinetic approach to clinical practice via Monte Carlo simulationsJean-Marie Conil, Bernard Georges, François Ravat, et al.
Fundamental & Clinical Pharmacology|September 25, 2016
Is the unbound concentration of atazanavir of interest in therapeutic drug monitoring?David Metsu, Patrick Seraissol, Pierre Delobel, et al.
Infection|February 28, 2019
Efficacy of teicoplanin monotherapy following initial standard therapy in Enterococcus faecalis infective endocarditis: a retrospective cohort studyThomas De Nadaï, Mathilde François, Agnès Sommet, et al.
Viruses|July 21, 2019
Plasma Hepatitis E Virus Kinetics in Solid Organ Transplant Patients Receiving RibavirinSebastien Lhomme, Swati DebRoy, Nassim Kamar, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|December 27, 2017
Determination of dolutegravir's unbound fraction in human plasma using validated equilibrium dialysis and LC-MS/MS methodsDavid Metsu, Thomas Lanot, François Fraissinet, et al.
Pageof 2